Ovarian Hyperstimulation Syndrome
Conditions
Keywords
frozen-thawed embryo replacement, GnRH agonist, GnRH antagonist, ovarian hyperstimulation
Brief summary
The aim of the study is to explore the concept of GnRH-agonist triggering in combination with elective cryopreservation of all 2PN oocytes at larger scale in a pragmatic clinical setting. The question asked is: Does GnRH-agonist triggering and cryopreservation work, in terms of efficacy and safety, when applied to a larger cohort of patients, and by a number of different centres with different clinical routines.
Interventions
None listed
Sponsors
Study design
Eligibility
Inclusion criteria
* Indication for IVF with ICSI * Age \< 40 years * \< 4 failed previous IVF attempts with embryo transfer * ovarian stimulation with GnRH-antagonist and gonadotrophins * \>20 follicles \>11 mm in mean diameter or E2 \>4500 pg/ml on the day , on which it was planned to administer hCG * willing to participate and able to consent * patient has not previously received GnRH-agonist as a trigger of final oocyte maturation
Exclusion criteria
* None
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Cumulative ongoing pregnancy rate (10-12 GWs) per patient within 12 months | 12 months after recruitment |
Secondary
| Measure | Time frame |
|---|---|
| Ongoing pregnancy rate/first frozen-thawed ET | 12 months after recruitment |
| time to pregnancy in weeks | 12 months after recruitment |
| incidence of OHSS III° | 12 months after recruitment |
| ongoing pregnancy rate/frozen-thawed ET | 12 months after recruitment |
| fertilization rate (number COCs/number of 2 PN oocytes | 12 months after recruitment |
| survival rate (number of vital embryos/number of frozen 2 PN oocytes | 12 months after recruitment |
| number of cumulus-oocyte-complexes | 12 months after recruitment |
Countries
Germany